Key facts
- Koeda’s last known valuation is $3.9M (Jun 2024).
- It has raised $640K; the latest was Early Stage VC in Mar 2026.
- Notable investors include Mitsubishi UFJ Capital, Intellectual Property Acceleration Program for Startups, Kawasaki-NEDO Innovation Center, TOHOKU University Venture Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Koeda
- ·The full record, as it builds
Funding rounds
No funding rounds for Koeda are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Koeda
Developer of an organ fixation anchor tool designed to fix hollow organs under an endoscope. The company's instrument can be inserted into an ultrasound-guided endoscopic needle to aid in the treatment of acute cholecystitis and other conditions, enabling the medical industry to provide effective treatment.
- Sector
- Healthcare
- HQ
- Sendai, Japan
- Founded
- 2022
- Employees
- 10
- Website
- koeda.co.jp/
- Ownership
- Privately Held (backing)
Koeda doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Koeda shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Koeda in its N-PORT filings yet. We sweep new filings monthly.